CEO has stated it twice:
1. In the Australian yesterday - ”Big Pharma is looking at cardio protection in particular” - CEO
2. Last Webinar 6 months ago - Will license out the drug for cardiovascular indication
https://m.youtube.com/watch?v=R8JcjS7jc5I&pp=ygUGTnlyYWRh
The are doing exactly what Aptoll has done after phase 2a they recieved a multi billion dollar license agreement and 200 million upfront payment from Merck. 37 million market cap makes it severely undervalued
- Forums
- ASX - By Stock
- NYR
- Ann: Phase I Clinical Trial Protocol Amendment
NYR
nyrada inc.
Add to My Watchlist
0.00%
!
24.5¢

Ann: Phase I Clinical Trial Protocol Amendment, page-11
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.67M |
Open | High | Low | Value | Volume |
24.5¢ | 25.0¢ | 24.5¢ | $94.01K | 380.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 165579 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 130000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 165579 | 0.240 |
1 | 70000 | 0.235 |
2 | 164126 | 0.230 |
7 | 168773 | 0.220 |
1 | 100000 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 130000 | 2 |
0.255 | 25000 | 1 |
0.260 | 54498 | 2 |
0.270 | 154139 | 2 |
0.275 | 405 | 1 |
Last trade - 14.46pm 24/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |